tiprankstipranks
Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
US Market
NWPHF
Newron Pharmaceuticals SpA
RESEARCH TOOLSreports

Newron Pharmaceuticals SpA (NWPHF) Financial Statements

Compare
11 Followers

Newron Pharmaceuticals SpA Financial Overview

Newron Pharmaceuticals SpA's market cap is currently $390.82M. The company's EPS TTM is $-0.7663458000000001; its P/E ratio is -38.37; Newron Pharmaceuticals SpA is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 19.25M€ 51.39M€ 9.06M€ 6.09M€ 5.76M
Gross Profit€ 0.00€ 51.39M€ 9.06M€ 6.09M€ 5.76M
Operating Income€ -4.73M€ 26.17M€ -11.63M€ -13.30M€ -12.36M
EBITDA€ -4.55M€ 25.94M€ -11.83M€ -13.32M€ -11.92M
Net Income€ -13.33M€ 15.84M€ -16.22M€ -17.49M€ -14.90M
Balance Sheet
Cash & Short-Term Investments€ 28.85M€ 9.83M€ 12.60M€ 22.77M€ 34.59M
Total Assets€ 40.02M€ 63.91M€ 25.87M€ 37.20M€ 50.49M
Total Debt€ 38.13M€ 50.47M€ 48.41M€ 45.66M€ 43.08M
Net Debt€ 25.96M€ 43.54M€ 42.08M€ 32.24M€ 18.06M
Total Liabilities€ 51.15M€ 62.45M€ 55.77M€ 51.23M€ 47.38M
Stockholders' Equity€ -11.13M€ 1.46M€ -29.91M€ -14.03M€ 3.11M
Cash Flow
Free Cash Flow€ 32.51M€ -17.63M€ -10.15M€ -11.11M€ -11.46M
Operating Cash Flow€ 32.56M€ -17.61M€ -10.14M€ -11.09M€ -11.45M
Investing Cash Flow€ -13.75M€ 3.16M€ 3.25M€ -317.00K€ 8.42M
Financing Cash Flow€ -13.52M€ 15.05M€ -192.00K€ -186.00K€ 14.83M
Currency in EUR

Newron Pharmaceuticals SpA Earnings and Revenue History

Income Statement >

Newron Pharmaceuticals SpA Debt to Assets

Balance Sheet >

Newron Pharmaceuticals SpA Cash Flow

Cash Flow >

Newron Pharmaceuticals SpA Forecast EPS vs Actual EPS

Earnings >